[1]
Montagnana M, Trenti T, Aloe R, Cervellin G, Lippi G. Human chorionic gonadotropin in pregnancy diagnostics. Clinica chimica acta; international journal of clinical chemistry. 2011 Aug 17:412(17-18):1515-20. doi: 10.1016/j.cca.2011.05.025. Epub 2011 May 25
[PubMed PMID: 21635878]
[2]
Ong S, Beebeejaun H. The effect of physiological urine dilution on pregnancy test results in complicated early pregnancies. British journal of obstetrics and gynaecology. 1999 Jan:106(1):87-8
[PubMed PMID: 10426268]
[3]
Cole LA. Immunoassay of human chorionic gonadotropin, its free subunits, and metabolites. Clinical chemistry. 1997 Dec:43(12):2233-43
[PubMed PMID: 9439438]
[4]
Greene DN, Schmidt RL, Kamer SM, Grenache DG, Hoke C, Lorey TS. Limitations in qualitative point of care hCG tests for detecting early pregnancy. Clinica chimica acta; international journal of clinical chemistry. 2013 Jan 16:415():317-21. doi: 10.1016/j.cca.2012.10.053. Epub 2012 Nov 15
[PubMed PMID: 23159297]
Level 2 (mid-level) evidence
[5]
Braunstein GD. False-positive serum human chorionic gonadotropin results: causes, characteristics, and recognition. American journal of obstetrics and gynecology. 2002 Jul:187(1):217-24
[PubMed PMID: 12114913]
[6]
Cole LA, Shahabi S, Butler SA, Mitchell H, Newlands ES, Behrman HR, Verrill HL. Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases. Clinical chemistry. 2001 Feb:47(2):308-15
[PubMed PMID: 11159780]
[7]
Marcillac I, Troalen F, Bidart JM, Ghillani P, Ribrag V, Escudier B, Malassagne B, Droz JP, Lhommé C, Rougier P. Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms. Cancer research. 1992 Jul 15:52(14):3901-7
[PubMed PMID: 1377600]
[8]
Alfthan H, Haglund C, Roberts P, Stenman UH. Elevation of free beta subunit of human choriogonadotropin and core beta fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease. Cancer research. 1992 Sep 1:52(17):4628-33
[PubMed PMID: 1324787]
[9]
Sheaff MT, Martin JE, Badenoch DF, Baithun SI. beta hCG as a prognostic marker in adenocarcinoma of the prostate. Journal of clinical pathology. 1996 Apr:49(4):329-32
[PubMed PMID: 8655711]
[10]
Lundin M, Nordling S, Carpelan-Holmstrom M, Louhimo J, Alfthan H, Stenman UH, Haglund C. A comparison of serum and tissue hCG beta as prognostic markers in colorectal cancer. Anticancer research. 2000 Nov-Dec:20(6D):4949-51
[PubMed PMID: 11326644]
[11]
Reisenbichler ES, Krontiras H, Hameed O. Beta-human chorionic gonadotropin production associated with phyllodes tumor of the breast: an unusual paraneoplastic phenomenon. The breast journal. 2009 Sep-Oct:15(5):527-30. doi: 10.1111/j.1524-4741.2009.00772.x. Epub 2009 Jul 13
[PubMed PMID: 19624411]
[12]
Kricka LJ. Human anti-animal antibody interferences in immunological assays. Clinical chemistry. 1999 Jul:45(7):942-56
[PubMed PMID: 10388468]
Level 3 (low-level) evidence
[13]
Check JH, Nowroozi K, Chase JS, Lauer C, Elkins B, Wu CH. False-positive human chorionic gonadotropin levels caused by a heterophile antibody with the immunoradiometric assay. American journal of obstetrics and gynecology. 1988 Jan:158(1):99-100
[PubMed PMID: 2447778]
[14]
Knight AK, Bingemann T, Cole L, Cunningham-Rundles C. Frequent false positive beta human chorionic gonadotropin tests in immunoglobulin A deficiency. Clinical and experimental immunology. 2005 Aug:141(2):333-7
[PubMed PMID: 15996198]
[15]
Fahy BG, Gouzd VA, Atallah JN. Pregnancy tests with end-stage renal disease. Journal of clinical anesthesia. 2008 Dec:20(8):609-13. doi: 10.1016/j.jclinane.2008.05.025. Epub
[PubMed PMID: 19100935]
[16]
Delbeke FT, Van Eenoo P, De Backer P. Detection of human chorionic gonadotrophin misuse in sports. International journal of sports medicine. 1998 May:19(4):287-90
[PubMed PMID: 9657371]
[17]
Griffey RT, Trent CJ, Bavolek RA, Keeperman JB, Sampson C, Poirier RF. "Hook-like effect" causes false-negative point-of-care urine pregnancy testing in emergency patients. The Journal of emergency medicine. 2013 Jan:44(1):155-60. doi: 10.1016/j.jemermed.2011.05.032. Epub 2011 Aug 10
[PubMed PMID: 21835572]
[19]
Cervinski MA, Lockwood CM, Ferguson AM, Odem RR, Stenman UH, Alfthan H, Grenache DG, Gronowski AM. Qualitative point-of-care and over-the-counter urine hCG devices differentially detect the hCG variants of early pregnancy. Clinica chimica acta; international journal of clinical chemistry. 2009 Aug:406(1-2):81-5. doi: 10.1016/j.cca.2009.05.018. Epub 2009 May 27
[PubMed PMID: 19477170]
Level 2 (mid-level) evidence
[20]
Davies S, Byrn F, Cole LA. Human chorionic gonadotropin testing for early pregnancy viability and complications. Clinics in laboratory medicine. 2003 Jun:23(2):257-64, vii
[PubMed PMID: 12848444]
[21]
Butts SF, Guo W, Cary MS, Chung K, Takacs P, Sammel MD, Barnhart KT. Predicting the decline in human chorionic gonadotropin in a resolving pregnancy of unknown location. Obstetrics and gynecology. 2013 Aug:122(2 Pt 1):337-343. doi: 10.1097/AOG.0b013e31829c6ed6. Epub
[PubMed PMID: 23969803]
[22]
Menczer J, Modan M, Serr DM. Prospective follow-up of patients with hydatidiform mole. Obstetrics and gynecology. 1980 Mar:55(3):346-9
[PubMed PMID: 7360433]